Skip to main content
Nancy Foldvary-Schaefer, DO, Neurology, Cleveland, OH, Cleveland Clinic

NancyRFoldvary-SchaeferDOMS

Neurology Cleveland, OH

Epilepsy, Neurophysiology, Sleep Medicine

Professor, Medicine, Case Western Reserve University School of Medicine

Dr. Foldvary-Schaefer is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Foldvary-Schaefer's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Neurology, 1993 - 1995
  • Loyola University
    Loyola UniversityResidency, Neurology, 1990 - 1993
  • Evanston HospitalInternship, Internal Medicine, 1989 - 1990
  • Chicago College of Osteopathic Medicine
    Chicago College of Osteopathic MedicineClass of 1988

Certifications & Licensure

  • NY State Medical License
    NY State License 2014 - 2020
  • FL State Medical License
    FL State License 2011 - 2016
  • CA State Medical License
    CA State License 2010 - 2016
  • OH State Medical License
    OH State License 1995 - 2023
  • IL State Medical License
    IL State License 1988 - 1999
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Clinical Neurophysiology
  • American Board of Psychiatry and Neurology Epilepsy
  • American Board of Psychiatry and Neurology Sleep Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • What Neurologists Need to Know About Sleep ApneaMay 2019

Press Mentions

  • FDA Puts ‘Boxed Warning’ on Ambien, Other Sleep Medications
    FDA Puts ‘Boxed Warning’ on Ambien, Other Sleep MedicationsMay 2nd, 2019
  • FDA Slaps Strongest Warning Label on Commonly-Used Sleep Aids for Potentially Dangerous Side Effects
    FDA Slaps Strongest Warning Label on Commonly-Used Sleep Aids for Potentially Dangerous Side EffectsMay 1st, 2019
  • The FDA Is Calling for Stronger Warnings on These Sleeping Pills
    The FDA Is Calling for Stronger Warnings on These Sleeping PillsMay 1st, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations